- Home
- Innovation Centers
innovation centers
Custom work & High quality
- Community
community
JOIN THE COMMUNITY
- About us
- News

UbiQ

UbiQ
UbiQ, founded in 2010 as a spin-out of the Netherlands Cancer Institute, develops and commercializes ubiquitin research tools, enabling drug discovery in the rapidly expanding ubiquitin field. Access to well defined ubiquitinated peptides and conjugates is of paramount importance for screening assays for the identification of new drugs, as well as for fundamental research and structural studies. Find out about how our reagents enable research at www.ubiqbio.com
Expertise: Reagent development in the ubiquitin field, using automated solid phase peptide synthesis and the application of warheads.

Contact
Alfred Nijkerk
Address
Matrix ONE, Science Park 301, 1098 XH Amsterdam
Phone number
Website
UbiQ, founded in 2010 as a spin-out of the Netherlands Cancer Institute, develops and commercializes ubiquitin research tools, enabling drug discovery in the rapidly expanding ubiquitin field. Access to well defined ubiquitinated peptides and conjugates is of paramount importance for screening assays for the identification of new drugs, as well as for fundamental research and structural studies. Find out about how our reagents enable research at www.ubiqbio.com
Expertise: Reagent development in the ubiquitin field, using automated solid phase peptide synthesis and the application of warheads.
Contact
Alfred Nijkerk
Address
Matrix ONE, Science Park 301, 1098 XH Amsterdam